PM Jan Aushadhi Kendras have saved Indians Rs 45,000 crore while expanding affordable healthcare across the country
New Delhi: In a written reply to the Lok Sabha on July 24, Union Minister for Chemicals and Fertilisers Jagat Prakash Nadda placed on record a milestone that has reshaped healthcare economics for crores of Indian households over the past twelve years: the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has saved citizens an estimated Rs 45,000 crore on medicine bills. As of June 30, 2026, the scheme’s Jan Aushadhi Kendras (JAKs) numbered 20,149 across the country, spread over 776 of India’s 784 districts. What began as a modest experiment in generic medicine retail has, under sustained government push, matured into one of the largest publicly-backed pharmacy networks anywhere in the world.
The idea of dedicated outlets selling unbranded, quality-tested generic medicines at a fraction of market prices was first floated in 2008. For years, the scheme grew haltingly, with barely a few hundred stores functioning by the middle of the following decade. It was only after the initiative was recast as the Pradhan Mantri Bhartiya Janaushadhi Pariyojana and given renewed political will that the network began to expand at a pace few welfare programmes in independent India have matched. By June 2021, the tally stood at 7,836 Kendras. It crossed 14,000 by 2024, when the scheme also achieved the distinction of crossing Rs 1,000 crore in annual medicine sales two months earlier than the previous year. By June 2025, the count had climbed to 16,912, with cumulative savings estimated at nearly Rs 38,000 crore over eleven years. Less than a year on, the network has added over 3,000 more outlets, pushing the total past 20,000 and savings past the Rs 45,000 crore mark. Few government schemes anywhere have shown this kind of compounding momentum, and the trajectory suggests the pace is only quickening.
Behind the headline figure there lies a simple but powerful economic logic. Jan Aushadhi medicines are priced 50 to 80 per cent lower than their branded equivalents and in several categories the difference runs even higher. For a country where out-of-pocket health expenditure has historically pushed families into debt or forced them to defer treatment altogether, this is not an abstract statistic but a lived relief. Every rupee saved on a strip of tablets for hypertension, diabetes or a chronic infection is a rupee that stays with a household for food, education or savings. The scheme’s own evaluation shows this relief has been felt most acutely in smaller towns and rural India, precisely the geography where private branded pharmacies are scarce and healthcare spending bites hardest into family budgets. Multiple national news agencies carried the government Parliament statement this week, underlining how the scheme has moved from a niche welfare measure to a mainstream pillar of Indian healthcare architecture.
A pharmacy network is only as useful as what it stocks, and here too the expansion has been deliberate. The PMBJP product basket today includes 2,110 medicines and 315 surgical items, consumables and devices, spanning cardiovascular disease, cancer, diabetes, infections, allergies, gastro-intestinal ailments and nutraceuticals. Almost every generic medicine on the National List of Essential Medicines, barring laboratory reagents and vaccines, now finds a place on Jan Aushadhi shelves. Since September 2024, the government has gone a step further by incentivising Kendra owners to maintain stocks of 200 commonly required medicines, a mix of the 100 best-selling drugs in the scheme and 100 fast-moving drugs in the wider market, with a monthly incentive tied to how well these stocks are maintained. This is a scheme learning from its own data and correcting course in real time, exactly the kind of administrative agility that critics of government programmes often claim is missing.
A question citizens ask frequently about the low-cost medicine is whether affordability comes at the cost of safety. The architecture built around PMBJP answers this directly. Medicines are sourced only from manufacturers certified under World Health Organisation Good Manufacturing Practices, and every batch is tested at laboratories accredited by the National Accreditation Board for Testing and Calibration Laboratories before it reaches a Kendra shelf. The Pharmaceuticals and Medical Devices Bureau of India, which implements the scheme, continuously evaluates Kendra performance and supply quality and appropriate corrective measures are taken wherever gaps in availability or standards are detected. This quality-first approach is what has allowed a scheme built around the word cheap to instead build a reputation for trust, gradually overturning the old and unfair assumption that low price must mean low quality.
The most underappreciated dimension of PMBJP is its entrepreneurship model. Jan Aushadhi Kendras are not run by the government directly but franchised out to individual entrepreneurs, non-governmental organisations, societies, trusts and private firms who apply online through the scheme’s portal, including from underserved blocks. Operators earn a retail margin along with a performance-linked monthly incentive, giving thousands of first-generation entrepreneurs a viable, low-investment business model. The government has layered on additional support for those who have historically found it hardest to access capital; a one-time incentive of Rs 2 lakh, split between furniture and computer equipment, is available to entrepreneurs opening Kendras in North-Eastern states, Himalayan and island territories and Aspirational Districts, as well as to ex-servicemen, women, persons with disabilities and members of Scheduled Castes and Scheduled Tribes. In recent months, the scheme has also been integrated with Primary Agriculture Credit Societies, opening a fresh income stream for rural cooperative members and pushing the network deeper into the countryside. A related initiative, Jan Aushadhi Suvidha sanitary napkins priced at just Re 1 per pad, has by early 2026 crossed 100 crore units sold, quietly advancing menstrual health access for women in both cities and villages while boosting footfall and revenue for Kendra operators, a genuine instance of social good and entrepreneurial opportunity reinforcing each other.
None of this would be sustainable without a supply chain capable of reaching every corner of the country. PMBJP now runs on an end-to-end, information-technology-enabled system built around one central warehouse and four regional warehouses, feeding a growing network of distributors. Around 400 fast-moving products are tracked continuously, with demand forecasting increasingly being digitised to sharpen procurement decisions and reduce the stock-outs that used to be a common complaint against the scheme in its early years. On the citizen-facing side, the Janaushadhi Sugam mobile application, downloaded by over 38 lakh Indians, lets users locate the nearest Kendra, compare generic and branded prices and check real-time availability of medicines, extending the scheme’s reach through the same digital public infrastructure that has transformed governance delivery elsewhere in the country.
Building trust in generic medicines required more than supply-side reform; it required a sustained conversation with the public. PMBI runs awareness campaigns in coordination with the Central Bureau of Communication, the Press Information Bureau, MyGov and MY Bharat, using print, television, radio, social media, outdoor hoardings and community engagement. Citizens are also reached through a WhatsApp chatbot and outbound calls that explain both the quality assurance behind Jan Aushadhi products and the savings on offer. Every year, the first week of March is observed as Jan Aushadhi Week, built around public rallies, health camps, seminars in pharmacy colleges and programmes for children, culminating in Jan Aushadhi Diwas on March 7. This year’s edition, the eighth since the day was instituted, carried the theme of linking the scheme’s health message with India’s cultural heritage. In rural areas, the outreach takes on a distinctly local flavour, with nukkad-natak street theatre, health camps and audiovisual displays at Common Service Centres carrying the message in local languages and dialects, ensuring the scheme speaks to citizens in idioms they recognise rather than in the language of government circulars.
The scale of the network growth is visible in state-level numbers. Uttar Pradesh leads the country in absolute terms with over 2,600 Kendras, followed by Bihar, Gujarat and Maharashtra, each with several hundred outlets of their own. For states such as Bihar and Odisha, where high out-of-pocket medical costs have historically pushed families toward poverty, the arrival of Jan Aushadhi Kendras in large numbers has been transformative, turning what were once simple retail counters into genuine lifelines. The scheme’s reach now extends even to India’s remotest frontiers, with functioning Kendras in the Andaman and Nicobar Islands, Arunachal Pradesh and Ladakh. In the tribal belts of Chhattisgarh and Madhya Pradesh, communities that once depended on informal or unregulated sources for medicine are increasingly turning to Jan Aushadhi outlets instead, a quiet but significant shift in public trust.
With 776 of 784 districts already covered, the government’s stated target of 25,000 Kendras by March 2027 now looks well within reach, and officials continue to work with district administrations to secure space in government hospitals for the handful of districts still uncovered. Twelve full years on, Jan Aushadhi has evolved from a modest, slow-moving welfare scheme into a genuine template for how Atmanirbhar Bharat can be built one Kendra, one entrepreneur and one affordable prescription at a time. As the network heads steadily toward its next set of milestones, it stands as one of the clearest examples of how sustained governance, rather than one-off announcements, ultimately delivers a Viksit Bharat within reach of every single citizen, regardless of pin code or income.
